Winston Medical Supply Co., Ltd. (TPEX:6817)

Market Cap	2.05B
Revenue (ttm)	695.08M
Net Income (ttm)	131.59M
Shares Out	18.42M
EPS (ttm)	7.12
PE Ratio	15.66
Forward PE	n/a
Dividend	7.00 (6.19%)
Ex-Dividend Date	Jun 13, 2025

Volume	28,022
Average Volume	38,535
Open	113.50
Previous Close	113.00
Day's Range	112.00 - 114.00
52-Week Range	85.70 - 117.50
Beta	0.06
RSI	57.87
Earnings Date	Aug 8, 2025

About Winston Medical Supply

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. It offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tables, film coated tablets, chewables, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1974
• Employees: 180
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6817

Financial Performance

In 2024, Winston Medical Supply's revenue was 695.08 million, a decrease of -1.97% compared to the previous year's 709.07 million. Earnings were 131.59 million, a decrease of -17.11%.